Logo image of NANO.CA

NANO ONE MATERIALS CORP (NANO.CA) Stock Fundamental Analysis

TSX:NANO - CA63010A1030 - Common Stock

1.03 CAD
-0.05 (-4.63%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

2

Overall NANO gets a fundamental rating of 2 out of 10. We evaluated NANO against 27 industry peers in the Chemicals industry. The financial health of NANO is average, but there are quite some concerns on its profitability. NANO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

NANO had negative earnings in the past year.
NANO had a negative operating cash flow in the past year.
In the past 5 years NANO always reported negative net income.
In the past 5 years NANO always reported negative operating cash flow.
NANO.CA Yearly Net Income VS EBIT VS OCF VS FCFNANO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

NANO has a Return On Assets of -24.45%. This is in the lower half of the industry: NANO underperforms 66.67% of its industry peers.
NANO has a Return On Equity of -47.13%. This is in the lower half of the industry: NANO underperforms 74.07% of its industry peers.
Industry RankSector Rank
ROA -24.45%
ROE -47.13%
ROIC N/A
ROA(3y)-67.37%
ROA(5y)-47.88%
ROE(3y)-77.65%
ROE(5y)-54.41%
ROIC(3y)N/A
ROIC(5y)N/A
NANO.CA Yearly ROA, ROE, ROICNANO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NANO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NANO.CA Yearly Profit, Operating, Gross MarginsNANO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, NANO has about the same amount of shares outstanding.
The number of shares outstanding for NANO has been increased compared to 5 years ago.
NANO has a worse debt/assets ratio than last year.
NANO.CA Yearly Shares OutstandingNANO.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
NANO.CA Yearly Total Debt VS Total AssetsNANO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -1.47, we must say that NANO is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.47, NANO is in line with its industry, outperforming 40.74% of the companies in the same industry.
A Debt/Equity ratio of 0.74 indicates that NANO is somewhat dependend on debt financing.
The Debt to Equity ratio of NANO (0.74) is better than 62.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF N/A
Altman-Z -1.47
ROIC/WACCN/A
WACCN/A
NANO.CA Yearly LT Debt VS Equity VS FCFNANO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

NANO has a Current Ratio of 6.49. This indicates that NANO is financially healthy and has no problem in meeting its short term obligations.
NANO has a better Current ratio (6.49) than 92.59% of its industry peers.
A Quick Ratio of 6.34 indicates that NANO has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 6.34, NANO belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.49
Quick Ratio 6.34
NANO.CA Yearly Current Assets VS Current LiabilitesNANO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

NANO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.33%, which is quite good.
EPS 1Y (TTM)13.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.62%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, NANO will show a decrease in Earnings Per Share. The EPS will decrease by -1.96% on average per year.
The Revenue is expected to grow by 98.57% on average over the next years. This is a very strong growth
EPS Next Y16.31%
EPS Next 2Y-1.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year166.64%
Revenue Next 2Y98.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

NANO.CA Yearly Revenue VS EstimatesNANO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 5M 10M 15M
NANO.CA Yearly EPS VS EstimatesNANO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.1 -0.2

0

4. Valuation

4.1 Price/Earnings Ratio

NANO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NANO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NANO.CA Price Earnings VS Forward Price EarningsNANO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NANO.CA Per share dataNANO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.96%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NANO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NANO ONE MATERIALS CORP

TSX:NANO (9/5/2025, 7:00:00 PM)

1.03

-0.05 (-4.63%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-12 2025-08-12
Earnings (Next)11-11 2025-11-11
Inst Owners8.42%
Inst Owner ChangeN/A
Ins Owners4.67%
Ins Owner ChangeN/A
Market Cap114.84M
Analysts80
Price Target5.1 (395.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)53.85%
PT rev (3m)108.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.95
P/tB 4.96
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0
BVpS0.21
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.45%
ROE -47.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-67.37%
ROA(5y)-47.88%
ROE(3y)-77.65%
ROE(5y)-54.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 44.87%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.49
Quick Ratio 6.34
Altman-Z -1.47
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)187.76%
Cap/Depr(5y)197.45%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.62%
EPS Next Y16.31%
EPS Next 2Y-1.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year166.64%
Revenue Next 2Y98.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year38.48%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-16.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.46%
OCF growth 3YN/A
OCF growth 5YN/A